Shizuoka, Japan

Shin-ichi Funahshi


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shin-ichi Funahshi: Innovator in Cancer Diagnosis and Treatment

Introduction

Shin-ichi Funahshi is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancer through innovative methods involving the ROBO1 protein.

Latest Patents

Funahshi holds a patent for a method of diagnosing cancer that involves detecting the ROBO1 protein. This patent outlines a comprehensive approach to treating diseases caused by abnormal cell growth. It includes the administration of an antibody that binds to ROBO1, along with a pharmaceutical composition, a cell growth inhibitor, and an anticancer agent that utilizes this antibody as an active ingredient. Additionally, the patent describes methods for inducing cell damage in ROBO1-expressing cells and inhibiting their growth by contacting them with the ROBO1-binding antibody. Furthermore, it presents a method for monitoring the progression of hepatitis through the detection of the ROBO1 protein.

Career Highlights

Throughout his career, Funahshi has worked with various organizations, including Perseus Proteomics Inc. His work has been pivotal in advancing the understanding of cancer and developing new therapeutic strategies.

Collaborations

Funahshi has collaborated with notable colleagues such as Hiroyuki Aburatani and Yoshitaka Hippo, contributing to the advancement of cancer research and treatment methodologies.

Conclusion

Shin-ichi Funahshi's innovative work in cancer diagnosis and treatment highlights his significant role in the scientific community. His contributions continue to pave the way for advancements in medical research and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…